Balance as of December 31, 2023

13,676,798

Issuance of units of securities (Note 12e)

603,904

Exercise of employee and consultant stock options (Note 12c)

106,132

Conversion of convertible loans into equity (Note 12d)

2,940,882

Balance as of December 31, 2024

17,327,716

Issuance of shares upon vesting of RSUs (Note 12j)

11,114

Exercise of investor warrants (Notes 12h and 12l)

1,291,523

Issuance of shares in public offering (Note 12m)

2,846,854

Exercise of employee and consultant stock options and warrants (Notes 12i and 12k)

19,877

Conversion of convertible loans into equity (Note 12g)

1,169,758

Balance as of December 31, 2025

22,666,842